Oral Biologics & Biosimilars Market, By Product Type (Proteins & Peptides, Monoclonal Antibodies, Hormones and Others), By Application, By Distribution, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
|
Report ID
AV5632
|
Published Date
July 2026
|
Pages
418
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Oral Biologics & Biosimilars Market size was valued at US$ 8,790.3 Million in 2025, expanding at a CAGR of 15.8% from 2026 to 2033.
The oral biologics & biosimilars market consists of biologics, biosimilars, and sophisticated biologics, which are used in oral delivery through drug delivery technologies that ensure protection against degradation in the gastrointestinal system and facilitate absorption. Unlike traditional injectable biologics, oral biologics have been formulated to increase ease of use and treatment adherence and for better disease management over a period of time.
The industry encompasses various categories such as oral proteins, peptides, monoclonal antibodies, hormones, and other sophisticated biologics, which have been formulated for the treatment of metabolic disorders, autoimmune disorders, gastrointestinal diseases, oncology, respiratory diseases, and neurological diseases. The market growth has been boosted by continuous advancements in oral delivery systems, enteric coatings, permeation enhancers, and capsule delivery systems, which help in efficient delivery and absorption of large molecules. Collaborations between pharmaceutical firms and drug delivery technology providers, increased biosimilar development, and expansion of biologics pipeline are contributing to growth.
Oral Biologics & Biosimilars Market- Market Dynamics
Advancements in oral biologic drug delivery technologies
Rising innovation in the technology of drug delivery via oral route is one of the primary drivers driving the market for oral biologics & biosimilars forward. Pharma companies are making efforts to invent capsule-based delivery mechanisms, permeation enhancing techniques, and formulations for the protection of protein, peptide, and monoclonal antibody drugs from destruction within the digestive tract. These developments have the potential to make life more convenient for patients and ensure improved treatment by reducing the requirement for administration through the injection route. An example of this is the collaboration of Rani Therapeutics with Chugai Pharmaceutical in October 2025 for the development of an oral antibody drug with the help of RaniPill® technology. The contract is worth up to USD 1.085 billion.
Oral Biologics & Biosimilars Market- Segmentation Analysis:
The Global Oral Biologics & Biosimilars Market is segmented on the basis of Product Type, Application, Distribution, and Region.
In terms of product type, the worldwide Oral Biologics & Biosimilars industry is estimated to be dominated by Proteins & Peptides segment. Growth is supported by the rising adoption of these drugs in the treatment of diabetes, obesity, and other metabolic diseases along with constant improvement in the methods of oral drug delivery. In addition, the successful commercialization of oral peptide drugs has instilled confidence in this category, and has paved the way for further pipeline expansion. As per Novo Nordisk\'s annual report of 2025, total revenue from Rybelsus® (oral semaglutide) in 2025 was worth DKK 23.7 billion, indicating high acceptance of peptide-based oral drugs among physicians and patients. Monoclonal Antibodies category is expected to be the future segment in oral biologics & biosimilars market as oral delivery technology of these drugs moves closer towards commercialization.
Oral Biologics & Biosimilars Market- Geographical Insights
North America region is accounted for the maximum revenue share in this market. Robust pipelines for biologics, high incidence of chronic diseases, and regulatory initiatives focused on enhancing biosimilar availability has supported the regional growth. Moreover, the U.S. FDA is actively involved in the approval of biosimilars, with proposals to reduce the need for switching studies for interchangeable biosimilars. Europe too will remain significant in the context of oral biologics & biosimilars, because the EMA centrally assesses majority of the biosimilars\' application along with providing scientific advice on biosimilars development. Asia Pacific will see steady growth driven by growing biologics production, government biosimilar guidelines, and increased access to advanced treatments in countries like India, China, Japan, and South Korea.
Oral Biologics & Biosimilars Market- Competitive Landscape:
The global market is driven by strategic alliances among pharma companies and oral drug delivery platform developers. Top competitors such as Novo Nordisk, Eli Lilly and Company, Novartis, Sanofi, AstraZeneca, and Rani Therapeutics are making significant investments in novel oral delivery systems, peptide drugs, and new generation biologics to increase their product portfolio offerings.
Major players are increasingly interested in enhancing the bioavailability, gastrointestinal stability, and patient compliance of their products without being heavily dependent on injectable forms. Some of the important strategies used by these players include licensing and technology partnerships along with pipeline expansion initiatives.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL ORAL BIOLOGICS & BIOSIMILARS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Novartis International AG
- Rani Therapeutics Holdings Inc.
- Eli Lilly and Company
- AstraZeneca plc
- Novo Nordisk A/S
- Biocon Limited
- Oramed Pharmaceuticals Inc.
- BiosanaPharma
- Entera Bio Ltd.
- Enteris BioPharma Inc.
- Chiesi Farmaceutici S.p.A.
- Sanofi S.A.
- Hoffmann-La Roche Ltd.
- Pfizer Inc.
- Sandoz International GmbH
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V. / Viatris Inc.
- Amgen Inc.
- Celltrion Inc.
- Samsung Bioepis
- Others
GLOBAL ORAL BIOLOGICS & BIOSIMILARS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2020 - 2033
- Proteins & Peptides
- Monoclonal Antibodies
- Hormones
- Others
GLOBAL ORAL BIOLOGICS & BIOSIMILARS MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Metabolic Disorders
- Autoimmune & Inflammatory Diseases
- Oncology
- Respiratory Diseases
- Neurology
- Gastrointestinal Disorders
- Others
GLOBAL ORAL BIOLOGICS & BIOSIMILARS MARKET, BY DISTRIBUTION- MARKET ANALYSIS, 2020 - 2033
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
GLOBAL ORAL BIOLOGICS & BIOSIMILARS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
TABLE OF CONTENTS
1. Oral Biologics & Biosimilars Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Oral Biologics & Biosimilars Market Snippet by Product Type
2.1.2. Oral Biologics & Biosimilars Market Snippet by Application
2.1.3. Oral Biologics & Biosimilars Market Snippet by Distribution
2.1.4. Oral Biologics & Biosimilars Market Snippet by Country
2.1.5. Oral Biologics & Biosimilars Market Snippet by Region
2.2. Competitive Insights
3. Oral Biologics & Biosimilars Key Market Trends
3.1. Oral Biologics & Biosimilars Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Oral Biologics & Biosimilars Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Oral Biologics & Biosimilars Market Opportunities
3.4. Oral Biologics & Biosimilars Market Future Trends
4. Oral Biologics & Biosimilars Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Oral Biologics & Biosimilars Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Oral Biologics & Biosimilars Market Landscape
6.1. Oral Biologics & Biosimilars Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Oral Biologics & Biosimilars Market – By Product Type
7.1. Overview
7.1.1. Segment Share Analysis, By Product Type, 2025 & 2033 (%)
7.1.2. Proteins & Peptides
7.1.3. Monoclonal Antibodies
7.1.4. Hormones
7.1.5. Others
8. Oral Biologics & Biosimilars Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
8.1.2. Metabolic Disorders
8.1.3. Autoimmune & Inflammatory Diseases
8.1.4. Oncology
8.1.5. Respiratory Diseases
8.1.6. Neurology
8.1.7. Gastrointestinal Disorders
8.1.8. Others
9. Oral Biologics & Biosimilars Market – By Distribution
9.1. Overview
9.1.1. Segment Share Analysis, By Distribution, 2025 & 2033 (%)
9.1.2. Hospital Pharmacies
9.1.3. Retail Pharmacies
9.1.4. Online Pharmacies
10. Oral Biologics & Biosimilars Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
10.2. North America
10.2.1. Overview
10.2.2. Oral Biologics & Biosimilars Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.2.4. North America Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.2.6. North America Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Oral Biologics & Biosimilars Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.6. Europe Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.3.8. UK
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.8.3. UK Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.8.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.8.5. UK Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.3.9. France
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.9.3. France Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.9.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.9.5. France Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.3.10. Italy
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.10.3. Italy Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.10.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.10.5. Italy Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.3.11. Spain
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.11.3. Spain Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.11.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.11.5. Spain Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.3.12. The Netherlands
10.3.12.1. Overview
10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.12.3. The Netherlands Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.12.5. The Netherlands Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.3.13. Sweden
10.3.13.1. Overview
10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.13.5. Sweden Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.3.14. Russia
10.3.14.1. Overview
10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.14.3. Russia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.14.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.14.5. Russia Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.3.15. Poland
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.15.3. Poland Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.15.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.15.5. Poland Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.3.16. Denmark
10.3.16.1. Overview
10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.16.3. Denmark Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.16.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.16.5. Denmark Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.3.17. Rest of Europe
10.3.17.1. Overview
10.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.17.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.17.5. Rest of the Europe Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Oral Biologics & Biosimilars Key Manufacturers in Asia Pacific
10.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.4.4. APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.6. APAC Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.4.7. China
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.7.3. China Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.7.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.7.5. China Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.4.8. India
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.8.3. India Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.8.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.8.5. India Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.4.12. Indonesia
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.12.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.12.5. Indonesia Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.4.13. Thailand
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.13.3. Thailand Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.13.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.13.5. Thailand Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.4.15. Taiwan
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.15.3. Taiwan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.15.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.15.5. Taiwan Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.4.16. Vietnam
10.4.16.1. Overview
10.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.16.3. Vietnam Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.16.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.16.5. Vietnam Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.4.17. Rest of APAC
10.4.17.1. Overview
10.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.17.5. Rest of APAC Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.5. Latin America (LATAM)
10.5.1. Overview
10.5.2. Oral Biologics & Biosimilars Key Manufacturers in Latin America
10.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.5.4. LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.6. LATAM Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.6. Middle East and Africa (MEA)
10.6.1. Overview
10.6.2. Oral Biologics & Biosimilars Key Manufacturers in Middle East and Africa
10.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.6.4. MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.6.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.6. MEA Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.6.8. UAE
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.8.3. UAE Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.6.8.4. UAE Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.8.5. UAE Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.6.13. Iran
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.13.3. Iran Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.6.13.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.13.5. Iran Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.6.14. Qatar
10.6.14.1. Overview
10.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.14.3. Qatar Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.6.14.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.14.5. Qatar Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.6.15. Rest of MEA
10.6.15.1. Overview
10.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.15.5. Rest of MEA Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
11. Key Vendor Analysis- Oral Biologics & Biosimilars Industry
11.1. Competitive Benchmarking
11.1.1. Competitive Dashboard
11.1.2. Competitive Positioning
11.2. Company Profiles
11.2.1. Novartis International AG
11.2.2. Rani Therapeutics Holdings Inc.
11.2.3. Eli Lilly and Company
11.2.4. AstraZeneca plc
11.2.5. Novo Nordisk A/S
11.2.6. Biocon Limited
11.2.7. Oramed Pharmaceuticals Inc.
11.2.8. BiosanaPharma
11.2.9. Entera Bio Ltd.
11.2.10. Enteris BioPharma Inc.
11.2.11. Chiesi Farmaceutici S.p.A.
11.2.12. Sanofi S.A.
11.2.13. F. Hoffmann-La Roche Ltd.
11.2.14. Pfizer Inc.
11.2.15. Sandoz International GmbH
11.2.16. Teva Pharmaceutical Industries Ltd.
11.2.17. Mylan N.V. / Viatris Inc.
11.2.18. Amgen Inc.
11.2.19. Celltrion Inc.
11.2.20. Samsung Bioepis
11.2.21. Others
12. 360 Degree AnalystView
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL ORAL BIOLOGICS & BIOSIMILARS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Novartis International AG
- Rani Therapeutics Holdings Inc.
- Eli Lilly and Company
- AstraZeneca plc
- Novo Nordisk A/S
- Biocon Limited
- Oramed Pharmaceuticals Inc.
- BiosanaPharma
- Entera Bio Ltd.
- Enteris BioPharma Inc.
- Chiesi Farmaceutici S.p.A.
- Sanofi S.A.
- Hoffmann-La Roche Ltd.
- Pfizer Inc.
- Sandoz International GmbH
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V. / Viatris Inc.
- Amgen Inc.
- Celltrion Inc.
- Samsung Bioepis
- Others
GLOBAL ORAL BIOLOGICS & BIOSIMILARS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2020 - 2033
- Proteins & Peptides
- Monoclonal Antibodies
- Hormones
- Others
GLOBAL ORAL BIOLOGICS & BIOSIMILARS MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Metabolic Disorders
- Autoimmune & Inflammatory Diseases
- Oncology
- Respiratory Diseases
- Neurology
- Gastrointestinal Disorders
- Others
GLOBAL ORAL BIOLOGICS & BIOSIMILARS MARKET, BY DISTRIBUTION- MARKET ANALYSIS, 2020 - 2033
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
GLOBAL ORAL BIOLOGICS & BIOSIMILARS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
